OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(20)
Release Date
2021
(4)
2024
(3)
2022
(2)
2013
(2)
2011
(2)
2010
(2)
2025
(1)
2019
(1)
2018
(1)
2016
(1)
2008
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Proteorhodopsin variability and distribution in the North Pacific Subtropical Gyre.
Not available
S-EPMC5864233
|
biostudies-literature
Cite
A distinct lineage of giant viruses brings a rhodopsin photosystem to unicellular marine predators.
Not available
S-EPMC6789865
|
biostudies-literature
Cite
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Not available
S-EPMC5200636
|
biostudies-literature
Cite
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Not available
S-EPMC2937272
|
biostudies-literature
Cite
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Not available
S-EPMC4356534
|
biostudies-literature
Cite
Results of the two incidence screenings in the National Lung Screening Trial.
Not available
S-EPMC4307922
|
biostudies-literature
Cite
The National Lung Screening Trial: overview and study design.
Not available
S-EPMC3009383
|
biostudies-literature
Cite
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study.
Not available
S-EPMC11578795
|
biostudies-literature
Cite
Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
Not available
S-EPMC4162127
|
biostudies-literature
Cite
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Not available
S-EPMC2748264
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets